Pulmonx (LUNG) Profit After Tax (2019 - 2025)

Pulmonx (LUNG) has reported Profit After Tax for 7 consecutive years, with -$14.4 million the latest figure, recorded in Q3 2025.

• On a quarterly basis, Profit After Tax fell 1.49% year-over-year to -$14.4 million in Q3 2025; TTM through Sep 2025 was -$57.6 million, a 0.81% decrease from a year earlier, with the FY2024 full-year figure at -$56.9 million, up 6.45% from the prior year.
• Profit After Tax was -$14.4 million for Q3 2025 at Pulmonx, up from -$15.2 million in the prior quarter.
• Over five years, Profit After Tax peaked at -$10.2 million in Q3 2021 and troughed at -$16.2 million in Q2 2023.
• A 5-year average of -$14.2 million and a median of -$14.2 million in 2022 frame the typical range for Profit After Tax.
• Across the five-year window, Profit After Tax tumbled 163.76% in 2021 and climbed 13.31% in 2024, its largest moves.
• Over 5 years, Profit After Tax stood at -$12.9 million in 2021, then slipped by 9.64% to -$14.1 million in 2022, then grew by 1.54% to -$13.9 million in 2023, then gained by 2.1% to -$13.6 million in 2024, then slipped by 5.58% to -$14.4 million in 2025.
• The last three Profit After Tax figures came in at -$14.4 million (Q3 2025), -$15.2 million (Q2 2025), and -$14.4 million (Q1 2025), per Business Quant data.